Ignite Creation Date:
2024-05-05 @ 11:53 PM
Last Modification Date:
2024-10-26 @ 10:41 AM
Study NCT ID:
NCT01441193
Status:
TERMINATED
Last Update Posted:
2016-03-04
First Post:
2011-09-26
Brief Title:
A Phase I Safety and Immunogenicity Preventive Vaccine Trial Based on the HIV-1 Tat and V2-deleted Env Proteins ISS P-002
Sponsor:
Barbara Ensoli MD
Organization:
Istituto Superiore di Sanità
Organization Data
Organization:
Istituto Superiore di Sanità
Class:
OTHER
Study ID:
ISS P-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Barbara Ensoli MD
Lead Sponsor Class:
OTHER
Responsible Party:
Barbara Ensoli MD
Responsible Party Title:
PhD
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Istituto Superiore di Sanità
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Novartis Vaccines | INDUSTRY |